SCHEMBL18596

SCHEMBL18596

C[C@H]1CNC(=O)CN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(F)(F)F)cc1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 14/20 0.60
GCK P35557 6/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19030 1.00 GCKR (0.60) GCKRGCK
SCHEMBL18327 0.93 GCK (0.71) GCKRGCK
SCHEMBL17143 0.93 GCK (0.71) GCKRGCK
SCHEMBL18729 0.93 GCK (0.71) GCKRGCK
SCHEMBL18599 0.93 GCK (0.71) GCKRGCK
SCHEMBL12078575 0.93 GCK (0.71) GCKRGCK
SCHEMBL12090048 0.92 GCKR (0.61) GCKRGCK
SCHEMBL12090105 0.92 GCKR (0.61) GCKRGCK
SCHEMBL12090029 0.92 GCKR (0.61) GCKRGCK
SCHEMBL19995 0.84 GCKR (0.59) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431563-B2 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes AMGEN INC. (US) 2013-04-30 US disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed